R&D News | pharmaphorum

Tuesday 5 May 2026

News

News

Talking vaccines: Industry’s role in protecting the Gavi generation

AZ mulls trial of new COVID-19 vaccine dose as UK regulator ...

AstraZeneca is to run an additional global trial to test its COVID-19 vaccine at a lower dosage, as the UK regulator begins to review trial data.

News

The SARS-CoV-2 coronavirus

Concerns emerge after AZ's lucky vaccine trial 'mistake'

AstraZeneca may have tried a positive spin on the trial mistake that led to the accidental discovery of the low dose COVID-19 vaccine regime with the highest efficacy– but the revelation ha

News

novartis innit

Novartis set to overcome $14 billion patent cliff say analys...

Novartis’ pipeline is strong enough to overcome a $14 billion patent cliff as blockbuster drugs face generic competition in the coming years, analysts have said.

News

astrazeneca-sign

'Mistake' led to AZ's more effective lower-dose COVID-19 sho...

AstraZeneca's research chief has said that the more effective dosing regimen of its coronavirus vaccine was discovered by accident.

News

Merck&Co_photo

Merck & Co adds COVID-19 drug to pipeline with OncoImmune bu...

Merck & Co is to buy US biotech OncoImmune for at least $425m, adding a potential new therapy for COVID-19 to its pipeline.

News

SARS-CoV-2 coronavirus

AZ preps filings for COVID-19 jab, UK nears decision on Pfiz...

AstraZeneca is preparing to file its COVID-19 vaccine with regulators after phase 3 trial results showed it is up to 90% effective.